Galipeau J - Search Results

1

Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients.

Campeau PM, Rafei M, François M, Birman E, Forner KA, Galipeau J. Campeau PM, et al. Among authors: galipeau j. Mol Ther. 2009 Feb;17(2):369-72. doi: 10.1038/mt.2008.270. Epub 2008 Dec 16. Mol Ther. 2009. PMID: 19088705 Free PMC article.

2

Glucocorticoid-inducible retrovector for regulated transgene expression in genetically engineered bone marrow stromal cells.

Jaalouk DE, Eliopoulos N, Couture C, Mader S, Galipeau J. Jaalouk DE, et al. Among authors: galipeau j. Hum Gene Ther. 2000 Sep 1;11(13):1837-49. doi: 10.1089/10430340050129468. Hum Gene Ther. 2000. PMID: 10986557

3

The nonapoptotic pathway mediating thymidine kinase/ganciclovir toxicity is reduced by signal from adenovirus type 5 early region 4.

Katabi M, Yuan S, Chan H, Galipeau J, Batist G. Katabi M, et al. Among authors: galipeau j. Mol Ther. 2002 Feb;5(2):170-6. doi: 10.1006/mthe.2002.0521. Mol Ther. 2002. PMID: 11829524 Free article.

4

Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.

Eliopoulos N, Al-Khaldi A, Beauséjour CM, Momparler RL, Momparler LF, Galipeau J. Eliopoulos N, et al. Among authors: galipeau j. Gene Ther. 2002 Apr;9(7):452-62. doi: 10.1038/sj.gt.3301675. Gene Ther. 2002. PMID: 11938460

5

A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice.

Eliopoulos N, Al-Khaldi A, Crosato M, Lachapelle K, Galipeau J. Eliopoulos N, et al. Among authors: galipeau j. Gene Ther. 2003 Mar;10(6):478-89. doi: 10.1038/sj.gt.3301919. Gene Ther. 2003. PMID: 12621452

6

Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo.

Al-Khaldi A, Eliopoulos N, Martineau D, Lejeune L, Lachapelle K, Galipeau J. Al-Khaldi A, et al. Among authors: galipeau j. Gene Ther. 2003 Apr;10(8):621-9. doi: 10.1038/sj.gt.3301934. Gene Ther. 2003. PMID: 12692590

7

Marrow stromal cells for interleukin-2 delivery in cancer immunotherapy.

Stagg J, Lejeune L, Paquin A, Galipeau J. Stagg J, et al. Among authors: galipeau j. Hum Gene Ther. 2004 Jun;15(6):597-608. doi: 10.1089/104303404323142042. Hum Gene Ther. 2004. PMID: 15212718

8

Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells.

Eliopoulos N, Lejeune L, Martineau D, Galipeau J. Eliopoulos N, et al. Among authors: galipeau j. Mol Ther. 2004 Oct;10(4):741-8. doi: 10.1016/j.ymthe.2004.07.004. Mol Ther. 2004. PMID: 15451458 Free article.

9

Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice.

Eliopoulos N, Stagg J, Lejeune L, Pommey S, Galipeau J. Eliopoulos N, et al. Among authors: galipeau j. Blood. 2005 Dec 15;106(13):4057-65. doi: 10.1182/blood-2005-03-1004. Epub 2005 Aug 23. Blood. 2005. PMID: 16118325 Free article.

10

Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.

Perri SR, Nalbantoglu J, Annabi B, Koty Z, Lejeune L, François M, Di Falco MR, Béliveau R, Galipeau J. Perri SR, et al. Among authors: galipeau j. Cancer Res. 2005 Sep 15;65(18):8359-65. doi: 10.1158/0008-5472.CAN-05-0508. Cancer Res. 2005. PMID: 16166313

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters